Lilly Shares Jump On 7.9% Weight Loss Pill Eli Lilly said on Thursday its experimental pill, orforglipron, led to weight loss of nearly 8% at the highest dose and lowered blood sugar in patients with type 2 diabetes in a late-stage trial. By ryounglao|2025-04-17T10:33:19-04:00April 17, 2025|International News|0 Comments Share This Story, Choose Your Platform! FacebookTwitterRedditLinkedInWhatsAppTumblrPinterestVkXingEmail About the Author: ryounglao Related Posts Warner Bros. Begins Exclusive Deal Talks With Netflix Warner Bros. Begins Exclusive Deal Talks With Netflix Oil Holds Two-Day Gain With Focus On Ukraine Talks And Surplus Oil Holds Two-Day Gain With Focus On Ukraine Talks And Surplus S&P 500 Futures Push Higher With Record In Sight S&P 500 Futures Push Higher With Record In Sight Airbus Cuts 2025 Delivery Target Due To A320 Fuselage Panel Issue Airbus Cuts 2025 Delivery Target Due To A320 Fuselage Panel Issue Leave A Comment Cancel replyComment Save my name, email, and website in this browser for the next time I comment. Δ
Leave A Comment